| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Former 10% Owner +1 more
17 companies
Baker Bros. Advisors LP is a Director, 10% Owner at ACAD with holdings across 17 companies. Recent SEC Form 4 filings include 84 buys and 4 sells.
Estimated insider holdings value: $7413.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | KOD Kodiak Sciences Inc. | Director, 10% Owner | Buy | 2,608,696 | $23.00 | $60,000,008.00 | +15.1% | -16.3% | - | |
| Dec 11, 2025 | KYMR Kymera Therapeutics, Inc. | Director, 10% Owner | Buy | 2,005,813 | $86.00 | $172,499,918.00 | +30.2% | -7.2% | - | |
| Nov 20, 2025 | TRDA Entrada Therapeutics, Inc. | 10% Owner | Buy | 28,867 | $9.07 | $261,846.12 | +0.3% | +20.4% | - | |
| Nov 12, 2025 | TRDA Entrada Therapeutics, Inc. | 10% Owner | Buy | 178,044 | $7.60 | $1,352,586.68 | +0.6% | +35.1% | - | |
| Oct 1, 2025 | KALA Kala Bio, Inc. | Former 10% Owner | Sell | 730,408 | $1.45 | $1,056,722.08 | -33.4% | -58.4% | - | |
| Sep 8, 2025 | CELC Celcuity Inc. | 10% Owner | Buy | 170,100 | $56.27 | $9,571,318.56 | +1.1% | +66.4% | - | |
| Aug 20, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 97,065 | $380.58 | $36,941,197.13 | +0.4% | +42.7% | - | |
| Aug 18, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 68,618 | $364.04 | $24,979,827.15 | +0.2% | +41.4% | - | |
| Jun 30, 2025 | KYMR Kymera Therapeutics, Inc. | Director | Buy | 655,500 | $44.00 | $28,842,000.00 | +10.9% | +34.1% | - | |
| Mar 17, 2025 | IMCR Immunocore Holdings Plc | Director | Buy | 807,338 | $29.72 | $23,993,223.80 | +21.6% | +9.6% | +2.3% |